Top 10 articles viewed in April 2023 on dicardiology.com

As we head into Spring, let's take a look at the Top 10 topics that viewers were reading about during the month of April.

1. Atrial Fibrillation Market Reaches $20.92B, According to New Report

2. BLOG: Making a Case for the Variable Rate Contrast Injector

April 28, 2023 — A long-term analysis designed by Christian Gerges and Irene Lang at the Department of Medicine II of the University Hospital Vienna and MedUni Vienna indicates that one third of patients with chronic thromboembolic pulmonary hypertension (CTEPH) also have left heart disease.

April 28, 2023 — Windtree Therapeutics, Inc. is a biotechnology company focused on advancing late-stage interventions for acute cardiovascular disorders of acute heart failure and a lead program studying istaroxime in cardiogenic shock. Cardiogenic shock is caused by a failing heart resulting in diminished cardiac output to the body and is characterized by very low blood pressure and hypoperfusion to end-organs.

April 28, 2023 — Medtronic today shared additional 36-month data from the IN.PACT AV Access Study, as well as 48-month vital status outcomes.

April 27, 2023 — New research suggests that even mild cases of COVID-19 can have long-term detrimental effects on cardiovascular health.  

April 27, 2023 — Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been granted FDA Breakthrough Device Status for its AI-enhanced platform for detecting cardiac amyloidosis. 

April 27, 2023 — Interventional cardiologists at Henry Ford Health are the first in Michigan to treat a patient using the Impella RP Flex with SmartAssist, one of the world’s smallest heart pumps. 

April 26, 2023 — Medtronic today announced its Endurant abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term durability through proven outcomes in a real-world setting1.

April 26, 2023 —Ascend Cardiovascular, a leader in cardiovascular structured reporting and workflow solutions is partnering with Us2.ai to add fully automated 

April 26, 2023 — In the majority of cases, graft failure after heart transplantation is attributable to abnormalities like severe coronary artery disease. As donors with extended criteria like advanced age and pre-existing heart conditions become eligible for heart transplantation, careful screening for congenital abnormalities has become crucial.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now